Table 1.
Patient Demographics, Clinical Data, and Angiographic Data (N = 338)
| Age, y, mean (range) | 57.8 (32–78) |
|---|---|
| Male, n (%) | 232 (68.6) |
| BMI (kg/m2) | 25.1 ± 3.1 |
| Hypertension, n (%) | 197 (58.4) |
| Diabetes, n (%) | 80 (23.7) |
| Hypercholesterolemia, n (%) | 60 (17.8) |
| Positive family history of IHD, n (%) | 40 (11.9) |
| Previous and current smoking, n (%) | 163 (48.3) |
| Alcohol habit, n (%) | 117 (34.7) |
| Infarct‐related artery, n (%) | |
| LAD | 166 (49.2) |
| RCA | 126 (37.3) |
| LCX | 34 (10.1) |
| Other | 12 (3.5) |
| Stents | |
| No. of stents, mean (range) | 1.3 (1–4) |
| Drug‐eluting stent (%) | 77 |
| Bare‐metal stent (%) | 7 |
| Multiple stents (%) | 16 |
| Lesions | |
| Occlusion, n (%) | 269 (79.7) |
| No. of lesions, mean (range) | 1.3 (1–5) |
| Time to treatment (min) | 169 (30∼724) |
| Heart rate (bpm) | 87 ± 22 |
| LVEF (%) | 55 ± 12 |
| Medical therapy, n (%) | |
| Aspirin | 324 (96.0) |
| Clopidogrel | 331 (97.9) |
| Nitrates | 291 (86.1) |
| ACE inhibitors | 180 (53.3) |
| β‐Blockers | 209 (61.8) |
| Calcium channel blockers | 46 (13.6) |
| Statins | 327 (96.7) |
| Digoxin | 86 (25.4) |
| Antiarrhythmic drugs | 26 (7.7) |
Abbreviations: ACE, angiotensin‐converting enzyme; BMI, body mass index; IHD, ischemic heart disease; LAD, left anterior descending artery; LCX, left circumflex coronary artery; LVEF, left ventricular ejection fraction; RCA, right coronary artery.